01 1Dipharma SA
01 1NITISINONE
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-09-21
Pay. Date : 2021-08-02
DMF Number : 36026
Submission : 2021-07-31
Status : Active
Type : II
20
Dipharma Sa, based in Switzerland, is a pharmaceutical company.
One of their notable products is NITISINONE, with a corresponding US DMF Number 36026.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2021, and payment made on August 02, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
